Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly kinase inhibitors for cancer treatment. Its structure enables selective binding to enzyme active sites, making it valuable in developing targeted therapies. Also employed in research for designing new bioactive molecules due to its ability to mimic purine bases in nucleotide-binding proteins.